Research relevant to MACRO HRD platform science.

The article emphasizes that broad-spectrum antiviral technologies are essential for pandemic preparedness. It discusses how engineered peptides, nanoparticles, and other materials-based approaches can directly target virus particles, disrupt viral membranes, and potentially reduce viral infectivity before host-cell infection occurs.

The work is relevant to Macro HRD's infectious disease focus because it supports the scientific rationale behind broad-spectrum antiviral platforms, including peptide-based and nanotechnology-enabled therapeutic strategies.

The article connects nanomaterials, self-assembly, biosensors, nanomedicine, drug delivery, and medical-device concepts to antiviral drug development and pandemic preparedness. It also frames membrane-enveloped viruses as a recurring source of epidemic risk across human medicine and agricultural biosecurity.

This publication is relevant to MACRO HRD's AH-D peptide and infectious disease platform narrative because it supports the scientific logic for targeting shared physical features of membrane-enveloped viruses rather than relying only on virus-specific mechanisms.

The article discusses nanomaterial-enhanced viral replication inhibitors, biomimetic virus particle capture schemes, and nanoparticle vaccine systems, with COVID-19-related examples and broader pandemic preparedness context.

This publication is relevant to MACRO HRD's infectious disease platform narrative because it connects nanomaterial design principles with virus targeting, antiviral development, and next-generation vaccine strategies.

The article summarizes how biomimetic platforms can be used to study virus-like membrane systems and evaluate broad-spectrum antiviral candidates. It focuses on the lipid envelope antiviral disruption strategy, known as LEAD, which targets the structural integrity of viral membranes to reduce or eliminate viral infectivity.

The paper also highlights tethered lipid vesicle platforms that mimic viral membranes and allow researchers to measure peptide-induced membrane destabilization, curvature selectivity, membrane permeabilization, and membrane lysis. These tools support the rational design and optimization of antiviral peptides, including curvature-sensitive alpha-helical peptides with broad-spectrum antiviral potential.

This publication is highly relevant to Macro HRD's AH-D peptide and infectious disease technology narrative because it explains the biophysical basis for developing antiviral agents that target membrane-enveloped viruses.

The review introduces current knowledge about antimicrobial lipids, including their structural classification, antibacterial spectrum, testing strategies, and membrane-destabilizing mechanisms.

This publication is relevant to MACRO HRD's lipid and membrane science narrative because it explains how fatty acids and monoglycerides interact with phospholipid membranes and bacterial cell membranes through both biological and biophysical measurement approaches.

The paper describes the LEAD strategy, or lipid envelope antiviral disruption, in which an engineered brain-penetrating peptide directly targets the lipid envelope of virus particles to reduce viral infectivity and viral spread.

This publication is highly relevant to MACRO HRD's AH-D peptide positioning because it connects peptide engineering, membrane-curvature targeting, blood-brain barrier penetration, and in vivo antiviral therapeutic evaluation.

The study shows that an AH-D peptide can disrupt tumour-derived exosomes and reduce exosomal PD-L1-related immunosuppressive activity, supporting enhanced response to PD-1 antibody-based immune checkpoint blockade therapy.

This publication is relevant to MACRO HRD's platform narrative because it extends curvature-sensitive peptide engineering from antiviral membrane targeting to exosome-targeting applications in cancer immunotherapy research.

The paper shows that AH and C5A peptides interact with lipid membranes through distinct mechanisms. AH peptide demonstrates curvature-sensitive membrane disruption through pore formation, while C5A shows a less selective membrane-solubilizing profile.

This publication is relevant to MACRO HRD's AH-D peptide platform because it provides structure–function insight for engineering membrane-active antiviral peptides with improved targeting selectivity and reduced host-cell toxicity risk.

The study extends single-particle membrane models into controlled viral membrane clusters, helping researchers evaluate how membrane-active antiviral peptides perform against clustered viral architectures.

This publication is relevant to MACRO HRD's platform narrative because it supports the experimental basis for testing antiviral peptide activity against virus-like lipid membrane systems beyond isolated single vesicles.

The paper provides mechanistic insight into how AH peptide selectively disrupts highly curved nanoscale lipid membranes, which are representative of lipid-enveloped virus particles. It also reports pore formation at medically relevant peptide concentrations and an unusually low peptide-to-lipid ratio.

This publication is highly relevant to MACRO HRD's AH-D peptide rationale because it supports the mechanistic foundation for curvature-sensitive targeting of small lipid-enveloped particles while avoiding larger host-cell membranes.

The work uses model lipid vesicles to connect nanoscale membrane size with peptide-induced rupture behavior. It helps frame why small, highly curved lipid-enveloped particles can be selectively targeted by membrane-active antiviral peptide strategies.

This publication is relevant to MACRO HRD's AH-D peptide narrative because it strengthens the biophysical foundation for broad-spectrum antiviral peptide activity against membrane-enveloped virus particles.

The study introduces the LUCA cycle, a controlled freeze–thaw–vortex process that generates distinctive onion-like concentric multilamellar cationic liposomes. These structural differences affect the optimal N/P charge ratio and final organization of mRNA lipoplexes.

This publication is relevant to MACRO HRD's lipid nanoparticle and delivery platform narrative because it supports the importance of lipid assembly structure, manufacturing method, and biophysical characterization in nucleic acid delivery systems.

The work combines fine-tuned language models, retrieval-augmented generation, agentic systems, and structured hypothesis generation to identify design ideas from plant science and materials engineering literature.

This publication is relevant to MACRO HRD's broader AI and materials-science context because it connects generative AI with structure-property reasoning and experimental materials design, although it is less directly tied to antiviral membrane targeting than the peptide and nanotechnology papers.

The analysis spans large HIV cohorts and shows that HLA expression levels can shape disease control beyond classical peptide-binding differences. It is a high-impact host-genetics paper connecting HLA regulation with HIV immune control.

This publication is relevant to MACRO HRD's infectious disease narrative because it supports the importance of host immunogenetics and HLA biology in HIV outcomes and patient-level response stratification.

The work connects regulatory variants, microRNA binding, and immune-disease outcomes, showing how host-genetic regulation of HLA expression can affect infectious disease and inflammatory disease phenotypes.

This publication is relevant because it supports the broader role of HLA expression regulation in HIV control and host-pathogen biology.

The paper helps explain heterogeneity among HLA-B*57-positive HIV controllers by identifying a functional KIR3DL1 variant associated with different levels of HIV control.

This publication is relevant to MACRO HRD's infectious disease platform context because it highlights how host immune-receptor genetics can alter clinical immune-control outcomes in HIV.

The paper links host hematologic and genetic factors with HIV acquisition risk, adding population-level context for infectious disease susceptibility in South African women.

This publication is relevant because it supports the importance of host genetic background, immune-cell biology, and regional cohort data in understanding HIV risk.

The article frames infection susceptibility as a product of host-pathogen interaction and regulatory genomic variation, not only coding-region variation.

This publication is relevant because it supports MACRO HRD's interest in host genetic and epigenetic regulation as part of infectious disease risk and outcome modeling.

The study connects BST-2 expression levels with DNA methylation and HIV disease biology, highlighting how host epigenetic mechanisms can influence antiviral restriction and viral pathogenesis.

This publication is relevant because it supports the role of epigenetic regulation in HIV outcomes and host-response analysis.

The work contrasts pediatric HIV immune control with HLA-B-restricted CD8+ T-cell-mediated control in adults, supporting age- and immune-system-specific interpretations of HIV control.

This publication is relevant because it expands the HLA and NK-cell biology context for HIV immune control and pediatric infectious disease outcomes.

The study provides insight into pediatric HIV nonprogression and immune adaptation, especially in the context of treatment interruption and persistent viremia.

This publication is relevant because it supports the clinical immunology and pediatric HIV context for evaluating disease progression and immune-control phenotypes.

The work connects antigen-presentation biology, tapasin dependence, and malaria outcome variation, extending the HLA expression and host-genetics theme beyond HIV.

This publication is relevant because it supports infectious disease host-genetics analysis across different pathogens and immune-presentation contexts.